ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 29 filers reported holding ELEDON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $321,680 | +99800.6% | 234,803 | 0.0% | 0.34% | +8.6% |
Q2 2023 | $322 | -41.9% | 234,803 | +0.0% | 0.31% | -52.3% |
Q1 2023 | $554 | +3.6% | 234,800 | 0.0% | 0.66% | +3.0% |
Q4 2022 | $535 | -99.9% | 234,800 | -4.2% | 0.64% | -15.4% |
Q3 2022 | $676,000 | +23.1% | 245,000 | +8.9% | 0.76% | +29.3% |
Q2 2022 | $549,000 | -38.1% | 225,000 | 0.0% | 0.58% | -21.6% |
Q1 2022 | $887,000 | +75.0% | 225,000 | +95.7% | 0.74% | +94.5% |
Q4 2021 | $507,000 | +9.3% | 115,000 | +53.3% | 0.38% | +10.7% |
Q3 2021 | $464,000 | -21.8% | 75,000 | 0.0% | 0.35% | -19.3% |
Q2 2021 | $593,000 | -26.2% | 75,000 | 0.0% | 0.43% | -28.1% |
Q1 2021 | $803,000 | – | 75,000 | – | 0.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 245,000 | $676,000 | 0.76% |
BVF INC/IL | 2,326,710 | $6,422,000 | 0.26% |
Cormorant Asset Management, LP | 1,223,500 | $3,377,000 | 0.24% |
Ikarian Capital, LLC | 221,830 | $612,000 | 0.12% |
JMAC ENTERPRISES LLC | 54,538 | $151,000 | 0.04% |
Woodline Partners LP | 516,675 | $1,426,000 | 0.02% |
Eversept Partners, LP | 67,743 | $186,971 | 0.02% |
INGALLS & SNYDER LLC | 51,149 | $141,000 | 0.01% |
Point72 Asset Management, L.P. | 375,000 | $1,035,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 22,050 | $61,000 | 0.00% |